tetramethyl Nordihydro<wbr/>guaiaretic Acid

tetramethyl Nordihydroguaiaretic Acid

CAT N°: 70302
Price:

23.00

tetramethyl Nordihydroguaiaretic acid (TMNDGA) is a synthetic derivative of NDGA, a non-selective lipoxygenase inhibitor. It inhibits Sp1 transcription factor binding at the HIV long terminal repeat promoter and at the ?-ICP4 promoter, a gene essential for HSV replication, with IC50 values of 11 and 43.5 µM respectively{16143,16144} TMNDGA induces growth arrest and apoptosis by suppressing Sp1-dependent Cdc2 and survivin gene expression giving rise to its antitumorigenic activity.{16147} The in vivo growth of xenografts in numerous human tumor types was suppressed upon treatment with TMNDGA.{16146} It also inhibits the growth of mouse and human melanomas and human colon cancer in vivo without causing other tissue toxicity.{16145} TMNDGA is currently in Phase I & II clinical trials for treatment of high grade glioma brain tumors.

We also advise you